JKphArma

Products

We develop existing lipophilic active principles under new galenic forms, enabling administration via the per-mucous sub-lingual route or the per-mucous gingivo-jugal route, in order to enhance efficacy, tolerance and acceptability.
Innovation | galenic form via the per-mucous sub-lingual route

Innovation | galenic form via the per-mucous sub-lingual route

The patented innovation is based on the pharmaceutical composition providing dual action

Read more
Innovation | galenic form via the per-mucous gingivo-jugal route

Innovation | galenic form via the per-mucous gingivo-jugal route

The innovation is based on the administration of the lipophilic neurotropic active ingredients via the trans-mucous buccal route, thereby...

Read more
Product pipeline

Product pipeline

Our product portfolio already consists of 7 Active Ingredients that enable us to pursue developments in a dozen therapeutic indications.

Read more